DIAGNOS Inc. (DGNOF)
- Previous Close
0.2409 - Open
0.2435 - Bid 0.2440 x --
- Ask 0.2582 x --
- Day's Range
0.2435 - 0.2435 - 52 Week Range
0.1800 - 0.3700 - Volume
4,300 - Avg. Volume
42,360 - Market Cap (intraday)
21.859M - Beta (5Y Monthly) -0.46
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date Nov 26, 2024 - Dec 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
DIAGNOS Inc. provides software-based services for healthcare sector in Canada, the United States, Mexico, Chile, and internationally. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.
www.diagnos.ca--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: DGNOF
View More
Performance Overview: DGNOF
Trailing total returns as of 10/28/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DGNOF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DGNOF
View MoreValuation Measures
Market Cap
21.73M
Enterprise Value
23.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
155.36
Price/Book (mrq)
--
Enterprise Value/Revenue
199.67
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-134.33%
Return on Equity (ttm)
--
Revenue (ttm)
163.53k
Net Income Avi to Common (ttm)
-3.09M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
637.73k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.72M
Company Insights: DGNOF
DGNOF does not have Company Insights